GlaxoSmithKline PLC (NYSE:GSK)

47.23
Delayed Data
As of Jan 24
 -0.59 / -1.23%
Today’s Change
38.16
Today|||52-Week Range
48.25
+0.51%
Year-to-Date
Where Will Intercept Pharmaceuticals Be in 5 Years?
Jan 23 / MotleyFool.com - Paid Partner Content
FDA Gives Clovis Oncology's Rubraca a Priority Review
Jan 15 / MotleyFool.com - Paid Partner Content
FDA Puts GlaxoSmithKline's Blood Cancer Drug In the Fast Lane
Jan 21 / MotleyFool.com - Paid Partner Content
Will Theravance Biopharma Finally Break Out in 2020?
Jan 14 / MotleyFool.com - Paid Partner Content
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Jan 16 / MotleyFool.com - Paid Partner Content
Is Pfizer's Stock a Buy?
Jan 14 / MotleyFool.com - Paid Partner Content
Here's Why Clovis Oncology Rose as Much as 25.6% Today
Jan 15 / MotleyFool.com - Paid Partner Content
Here's Why SpringWorks Therapeutics Climbed 69% in December
Jan 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close47.82
Today’s open48.23
Day’s range47.23 - 48.25
Volume6,967,885
Average volume (3 months)2,600,066
Market cap$119.5B
Data as of 6:30pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)+3.49%
Earnings growth (next 5 years)+4.70%
Revenue growth (last year)+5.72%
P/E ratio19.8
Price/Sales2.31
Price/Book21.23

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.87-1.75%
ABBVAbbVie-1.73-2.03%
NVONovo Nordisk-0.51-0.83%
AZNAstraZeneca-0.92-1.83%
Data as of 6:30pm ET, 01/24/2020

Financials

Next reporting dateFebruary 5, 2020
EPS forecast (this quarter)$0.68
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Brentford, Greater London

Forecasts